Investor
Relations

We are committed to developing transformational biologic medicines to serve patients with debilitating diseases

Presentations

Date	Title
Jan 05, 2022	AMT Corporate Presentation January 2022
Oct 15, 2021	AMT Research & Development Day Presentation